Diabetes technology

Social Determinants of Health and Continuous Glucose Monitoring Metrics in Type 1 or Type 2 Diabetes

JAMA Netw OpenPublished Retrospective cross-sectional study

Authors' conclusion

This cross-sectional study of adult and pediatric CGM users with type 1 or type 2 diabetes found that CGM and insulin pump use alone did not eliminate associations between SDOH and glycemic outcomes.

Study context

Population
Pediatric (<18 years) and adult (≥18 years) outpatients with T1D or T2D using continuous glucose monitoring (CGM) and meeting CGM data sufficiency criteria, single-centre academic health system, October 1, 2017–February 28, 2025; mean age 38.8 years, 53.1% female3,296 CGM profiles
Participants
1,743 participants
Exposure
Race, ethnicity, individual-level social determinants of health (SDOH) (eg, insurance type) and neighborhood-level socioeconomic status
Outcome
Glycemic outcomes: HbA1c, mean glucose, TIR, TAR, glycemic risk index, CV and extended hypoglycemic episodes
Methodological detailssingle-centre, inverse probability weighting, mixed-effects models
  • Single-centre
  • Inverse probability weighting
  • Mixed-effects models

Main finding

As reported in the abstract

Associations of SDOH with glycemic metrics
Black race and public health insurance · Higher hemoglobin A1c (HbA1c)
estimate 0.55 % (95% CI 0.27%–0.82%)
Black race and public health insurance · Higher mean glucose
estimate 17.88 mg/dL (95% CI 3.69-32.07 mg/dL)
Public insurance · TIR (described as higher TIR)
estimate −3.56 % (95% CI −5.45% to −1.66%)
Public insurance · Higher TAR
estimate 3.49 % (95% CI 1.53%–5.46%)
Public insurance · Higher glycemic risk index
estimate 4.50 (95% CI 2.13–6.87)
Socioeconomic disadvantage · Increase in CV
estimate 3.26 (95% CI 0.81–5.70)

Observational data: associations, not effects.

Further findings

Subgroups: children

Associations were most pronounced among children experiencing more socioeconomic disadvantage and Black children across metrics

Original publication

Social Determinants of Health and Continuous Glucose Monitoring Metrics in Type 1 or Type 2 Diabetes. JAMA Netw Open. Published 1 July 2026. doi:10.1001/jamanetworkopen.2026.21290

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.